Fenimore Christopher R.
SEC insider (Form 3/4/5 filer). CIK 0001697422. EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in TARRYTOWN, NY.
Companies Fenimore Christopher R. has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Officer, EVP Finance CFO
Fenimore Christopher R.
CIK: 0001697422
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 18, 2026REGN
REGENERON PHARMACEUTICALS, INC.
Tax PaymentDirect4.6K shares at avg. $813.47$3.7M - Aug 18, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect6.3K shares at avg. $381.92$2.4M - Dec 8, 2025REGN
REGENERON PHARMACEUTICALS, INC.
Tax PaymentDirect992 shares at avg. $712.94$707K - Dec 5, 2025REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect3K shares- - Dec 16, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Tax PaymentDirect491 shares at avg. $730.81$359K - Dec 9, 2024REGN
REGENERON PHARMACEUTICALS, INC.
Tax PaymentDirect1.1K shares at avg. $787.00$897K - Dec 6, 2024REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect2.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment | 4,599 | $813.47 | $3,741,149 | Direct |
| Aug 18, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 6,283 | $381.92 | $2,399,603 | Direct |
| Dec 8, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment | 992 | $712.94 | $707,236 | Direct |
| Dec 5, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 3,027 | - | - | Direct |
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment | 491 | $730.81 | $358,828 | Direct |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Tax Payment | 1,140 | $787.00 | $897,180 | Direct |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 2,591 | - | $0 | Direct |
1-7 of 7 transactions